World Health Organization

This report provides a critical review of what is known about adherence to long-term therapies.This is achieved by looking beyond individual diseases. A broad range of policy options emerges by including communicable diseases such as tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), mental and neurological conditions such as depression and epilepsy, substance dependence (exemplified by smoking cessation), hypertension, asthma and palliative care for cancer.

This report provides a critical review of what is known about adherence to long-term therapies.This is achieved by looking beyond individual diseases. A broad range of policy options emerges by including communicable diseases such as tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), mental and neurological conditions such as depression and epilepsy, substance dependence (exemplified by smoking cessation), hypertension, asthma and palliative care for cancer.

This book is directed specifically to national TB control programs and their partners. It is intended to help select and implement the steps needed to ensure that the guiding principles of equity and poverty reduction are translated into practical measures - and that these practical measures are integrated into the national TB services and linked to broader poverty alleviation efforts.

This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited. The report demonstrates that lessons from a Latin American perspective on community-based TB care can help to understand and identify the role that the community plays in TB control in the region.

This guide assists in making TB control policy decisions and plans for successfully introducing fixed-dose combination drugs (FDCs). This guide is intended for national TB program managers, DOTS strategy implementers, drug procurement officers/personnel, DOT providers, and drug regulatory authorities.

This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited. The report demonstrates that lessons from a Latin American perspective on community-based TB care can help to understand and identify the role that the community plays in TB control in the region.

Aimed at provincial or district level staff responsible for training health facility staff who detect and treat cases of tuberculosis (TB), this guide explains options for using the course "Management of Tuberculosis: Training for Health Facility Staff." This guide is for the staff who will implement training at the provincial or district level, according to directives from the national level.

This book provides a basis for the diagnosis and management of tuberculosis. It is presented in a question-and-answer format, with subject matter grouped under the three headings: Case Detection, Treatment, and Monitoring.

This compendium report provides a detailed review of monitoring and evaluation (M&E) for national TB programs and indicators for measuring DOTS implementation and expansion. The review includes information on M&E for TB control programs, sources of data, and effective use of M&E data for program improvement and advocacy.

This book was developed to assist in the management of TB and HIV/AIDS programs that are implementing or planning to implement collaborative TB/HIV activities. It is intended to facilitate the collection of standardized data and help in the interpretation and dissemination of these data for program improvement. It aims to ensure consistency across all agencies and stakeholders involved in HIV/AIDS, TB, and collaborative TB/HIV activities.